Presymptomatic genetic testing for neurodegenerative diseases can help patients make effective treatment decisions, but the medical profession needs to ensure that the increasing use of the tests is done responsibly.
Doctor and parents have conflicting views and wishes in designing treatment plan for an 18-month-old child, critically ill with a rare form of pediatric cancer.